ScienceDaily
Your Brain Is Basically a Hoarder Who Refuses to Let You Lose Weight
Your brain is basically a hoarder who refuses to let you lose weight, but science is starting to pick the locks.
ScienceDaily
Your brain is basically a hoarder who refuses to let you lose weight, but science is starting to pick the locks.
The Guardian Europe
Weight-loss jabs come with a laundry list of side effects - from Ozempic face to hair loss - but many are just the body's dramatic reaction to rapid weight loss, not the drugs themselves.
ZDNet
A 50-something tech journalist loses 100+ pounds with Mounjaro and a parade of gadgets to hike the Camino, proving that GLP-1 drugs and smart scales make for a surprisingly good travel partnership.
BBC Business
Novo Nordisk sues Eli Lilly for false advertising in weight-loss drug wars, because nothing says 'healthy competition' like a courtroom drama.
BBC Business
Weight-loss jabs are reshaping grocery baskets: less chocolate, more mouthwash - and a £780m hit to UK food spending.
BBC Health
About 1.6 million Brits are on weight-loss jabs, but a new study finds stopping them means gaining weight back four times faster than quitting the gym - because the universe has a sense of humour.
The Guardian
GLP-1 users save £418 a year on groceries, eat less chocolate, and want smaller restaurant portions - but the drugs are so expensive that 41% quit.
BBC Health
A new drug aims to prevent the dreaded 'Ozempic butt' by preserving muscle during weight loss, because apparently your glutes deserve better than a deflated balloon look.
ScienceDaily
GLP-1 weight-loss drugs like Ozempic may reduce breast cancer risk by 30%, researchers say - though they’re not ready to call it a miracle cure just yet.
The Good Times
One sardonic roundup, delivered on your schedule. Free. Unsubscribe whenever your tolerance for wit runs out.
Already subscribed but we never reach your inbox? Check your spam folder and hit 'Not spam' (or 'Remove from spam') to bust us out of junk-mail purgatory. You'll be helping everyone else too.